Czechia vs Turkey: Cause of death, by non-communicable diseases, ages 60+, male
Czechia
70.9%
in 2021
Turkey
70.3%
in 2021
Czechia rank
81st
Turkey rank
83rd
Cause of death, by non-communicable diseases, ages 60+, male over time
- Czechia
- Turkey
How they compare
Czechia currently reports 70.9% against 70.3% in Turkey, a difference of 0.6%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Turkey ahead.
Czechia ranks 81st and Turkey ranks 83rd of 185 countries.
Across the 3 decades both report, Czechia averaged higher in 1 and Turkey in 2.
Head to head by decade
| Decade | Czechia | Turkey | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.7% | 94.9% | 1.3% | Turkey |
| 2010s | 91.1% | 94.4% | 3.3% | Turkey |
| 2020s | 76.0% | 75.4% | 0.6% | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Czechia or Turkey?
- Czechia, at 70.9% against 70.3% in Turkey as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Czechia and Turkey?
- 0.6%, with Czechia ahead.
- How many years of comparable data are there for Czechia and Turkey?
- 6 years are reported by both, from 2000 to 2021.
- How do Czechia and Turkey rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Czechia ranks 81st and Turkey ranks 83rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.